The association of the risk of suicide with cancer at different time points after a new cancer diagnosis is unclear. This study explored the suicide hazard at different time points after a first cancer diagnosis during the 1-year period before suicide. This case-crossover study included 2,907 suicide cases from 2002 to 2012 in Taiwan and compared the odds of suicide risk at different time points during one year after any cancer diagnosis with self-matched periods. The 13th month preceding the suicide date was used as the control period, and the hazard period was the duration from the 1st to 12th month in the conditional logistic regression for case-crossover comparisons. Among major groups of cancers, group of lip, oral cavity and pharynx cancers tended to have higher risk of suicide than other groups of cancers. The first month of cancer diagnosis was associated with the highest risk of suicide compared with the 13th month before suicide. The odds ratio (OR) of suicide were significantly in the first six months after cancer diagnosis but declined afterwards. For example, the adjusted OR was 3.47 [95% confidence interval (CI) 5 2.60-4.62] in the first month and 1.53 (95% CI 5 1.11-2.12) in the sixth month following cancer diagnosis. These findings provide clinicians with a vital reference period during which sufficient support and necessary referral to mental health support should be provided to reduce the risk of suicide among patients with newly diagnosed cancer morbidity.
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The substantial progress in cancer treatment has increased 5-year survival rates. However, cancer patients may instead have an elevated risk of cardiovascular mortality and suicide. [1] [2] [3] Acute stress reactions or post-traumatic stress syndrome are commonly observed in cancer patients after cancer diagnosis. 4, 5 Due to the uncertain trajectory and physical and emotional impact of cancer prognosis, patients may wish to commit suicide as a strategy to escape from painful symptoms or as an approach to release the stress resulting from the adverse effects of treatments. The poor quality of their subsequent lives and a lack of perceived meaning regarding survival also increase the tendency toward suicidal ideation, suicidal behavior and death. 6 Cancer patients exhibit at least a twofold higher incidence of suicide than the general population. 7, 8 Kam et al.
found that the incidence of suicide among patients with head and neck cancer is >3 times higher that of the general US population. 9 Risk factors for suicide include sex, age, cancer type, mental comorbidity and cancer prognosis. 7, [10] [11] [12] [13] [14] A distinct phenomenon is the higher suicide hazard observed within the short period following cancer diagnosis. 7 Miccinesi et al. reviewed suicide rates in cancer patients and found that 40% completed suicide within 1 year of their first cancer diagnosis. 15 Zaorsky et al. found that the highest suicide risk was within the first year following cancer diagnosis. 16 Fang et al. also found that the suicide rate within 1 week after cancer diagnosis could be as high as 2.5 per thousand person years and that the incidence rate ratio of suicide was 4.8 during the first 3 months after cancer diagnosis compared with that in patients without cancer diagnosis. 1 Fall et al. revealed an increased risk of suicide in prostate cancer patients within just 1 week of cancer diagnosis.
stomach or head and neck cancers is associated with relatively high risks of suicide. 18 Although the risk of suicide is elevated in the first year after cancer diagnosis, the suicide hazard at different time points after cancer diagnosis is still unknown. This study utilized a case-crossover design to adjust for individual variations and to analyze the differences in suicide hazard over a 1-year period before suicide. The case-crossover design was expected to eliminate the threat of control-selection bias resulting from the conventional case-control design. 19 This study explored the suicide hazard at different time points after the first cancer diagnosis during the 1-year period before suicide. We linked the national mortality dataset to the national healthcare insurance data set for the period 2000-2012 to evaluate the suicide hazard associated with a new cancer diagnosis in cancer patients in the last year before their deaths.
Methods

Data source
The Figure 1 displays the flow chart of sample selection procedure and data analytic plan in this study. We conducted a record-linkage study based mainly on the National Mortality Registry (NMR) and the National Health Insurance Research Database (NHIRD). The data were provided by the Health and Welfare Data Science Center, Ministry of Health and Welfare, Taiwan. The National Health Insurance program covers 99.5% of the Taiwanese population and the NHIRD contains diagnosis and reimbursement details including hospital admissions, outpatient and emergency visit records. The NHIRD can accurately represent actual medical utilization by Taiwan residents. 20 In Taiwan, all death information must be reported by physicians or forensic experts and must be officially registered in the NMR, which has been validated to be complete and have acceptable quality. 21 The background information of patients, including the marital status and the educational level of residents at the end of each year, was obtained from the Department of Household Registration, Ministry of Internal Affairs, Taiwan. Individual unique national registration numbers were used to link all aforementioned datasets. Marital status was categorized into married/common law, never married and divorced/widowed/unknown. Educational level was categorized into higher educational level (>12 years; i.e., college and graduate school) and lower educational level (Ϲ12 years; i.e., elementary, junior high school and senior high school). Low-income level was identified on the basis of receiving a subsidy that is provided for qualified lowincome NHI enrollees. Approximately 2% of the overall population of Taiwan qualifies as low-income households with highly disadvantaged financial situations.
Identification of cases
The study firstly identified suicide cases with all kinds of cancer diagnoses. Cancer groups were defined based on ICD codes and included all codes pertaining to malignant neoplasms (ICD-9 codes140-208). Cancer categories codes 140-195 were the classification of primary malignant neoplasms according to their points of origin, which were similar to ones in previous studies. 26 reported that distinguishable peaks were noted for cancer recurrence in the beginning years after diagnosis. Besides, close radiographic follow-up after curative resection is still recommended by most professional societies, with more frequent scanning in the first 2 years. 27 Taking 2 years as a washout period to exclude patients with cancer recurrence should be reasonable. Therefore, all patients with first cancer diagnoses after 2002 were included in this study, and the study period was defined as the 13-month duration preceding the suicide date. The major consideration to use the 13th month antecedent to the suicide death as the control index period was based on previous studies that showed the highest hazard period for suicide was within the first year following cancer diagnosis. 1, 15, 16 The control period therefore was chosen to account for potentially varying baseline risk over time. In this study, we planned to highlight the immediate impact of breaking a diagnosis of cancer and thus defined the 13th month antecedent to the suicide date as the control period. The odds of suicide were calculated monthly, and the length of each month was defined as 30 days.
Identification of case-crossover period
Because of the complex nature of suicide and its multiple associated factors, we used a case-crossover design to clarify the risk of suicide by comparing patients own data at different time points after their first cancer diagnosis. The length of time from cancer diagnosis to suicide (event) or censoring was calculated. Such a method has been successfully used in a previous study of cancer and suicide. 1 Based on our intent to investigate the risk of suicide within 1 year after cancer diagnosis, we divided 360 days antecedent to suicide into 12 monthly periods (i.e., the 1st to 12th month before suicide) and identified if a new cancer diagnosis was received in a specific month (hazard period). The 13th month before suicide (i.e., the 361-390 days) was used as the control period. We then estimated the odds by comparing rate of the first cancer diagnosis in each month (hazard period) to rate of the first cancer diagnosis in the 13th month (control period) preceding their own suicide. The clinicians do not know when suicide will occur but know when patients were diagnosis with cancer. It is less realistic to follow-up all patients who first had cancer diagnosis until their suicide. On the contrary, all suicide cases with cancer had their medical records available to provide timing information on the first cancer diagnosis. Because suicide is not a common event but sometimes relatively rare, the case-crossover design was used in this study. The time series tracked from completed suicide backward to the first cancer diagnosis. If the first cancer diagnosis was found in six months before one's suicide, then his/her suicide was observed six months after first cancer diagnosis.
Statistical analyses
In descriptive analysis, continuous variables are expressed as means and standard deviations (SDs), and categorical variables are expressed as numbers and percentages. Our primary outcome measure was the monthly odds ratio (OR) of suicide in new cancer patients by self-crossover comparisons. We also calculated the percentage of suicide in all causes of mortalities by each cancer type. The effects of the associated factors were estimated using conditional logistic regression analysis, which yielded OR, adjusted OR, 95% confidence limits and the corresponding p-values. Two-tailed tests with an a level of 0.05 were considered statistically significant. The statistics of the national cancer registry in Taiwan were used as a reference to investigate the variation of the mortality among the different types of cancers. 28 
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Results
In the final analysis, 2,907 patients were included who had received all type of cancer diagnoses from 2002 to 2012 and subsequently committed suicide. Table 1 shows the descriptive characteristics of these patients. Of the entire sample, 2,030 (69.8%) were men and 1,636 (56.3%) were married. The majority of these patients belonged to the 60-75 (n 5 1,269, 43.7%) and 46-60 year (n 5 1,125, 38.7%) age groups. The majority of the study patients (70.9%) had a lower educational level (12 years, senior high school), and 5.39% were qualified as low income level families. Table 2 elucidates the percentage of suicide in all mortality for each cancer type. The percentage was most noticeable in patients with lip, oral cavity and pharynx cancer (1.34%) and with bone, skin and breast cancer (1.23%). Although the death toll of liver and lung cancers were higher compared with others, an elevated percentage of suicide was not observed. In the subtype levels, furthermore, patients with pharynx cancer (1.67%) and prostate cancer (1.47%) tended to commit suicide before died of cancer and other causes. Table 3 shows the results of the case-crossover analysis in comparison with the 13th month preceding the suicide date. Among all the cases of completed suicide who had a new cancer diagnosis, the highest odds of having a new cancer diagnosis was within 1 month before completed suicide [OR 5 3.47, 95% confidence interval (CI) 5 2.60-4.62]. Although the magnitude of elevation in the odds of receiving a new cancer diagnosis decreased, the risk remained high within 6 months antecedent to completed suicide. Beyond 7 months before suicide, the odds of receiving a new cancer diagnosis were not significantly different from that in the control period (i.e., the 13th month). Among all 2,907 cancer patients who died by suicide, 1,185 (41%) suicide cases occurred within the first 12 months after the incident cancer diagnosis. In the case-crossover analysis, we found the risk of suicide was 3.47 times higher in the first month of cancer diagnosis than in the control period. Figure 2 shows the ORs calculated from the data in Table  3 . The X-axis means 1st to 13th month after cancer diagnosis. The monthly OR and 95% CI of suicide with the first cancer diagnosis are shown in the Y-axis. It is clear that the ORs were relatively high in the first 6 months after a new cancer diagnosis.
Discussion
Using national datasets and a case-crossover analysis, this study investigated the risk of suicide at different time points during one year after cancer diagnosis. The first month after a new cancer diagnosis was associated with the highest risk of suicide and the hazard intensity decreased gradually over Note: All types of cancers (ICD-9-CM codes 140-208) among suicide cases were included in the study.
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the following months. This elevated risk of suicide persisted for 6 months after the first cancer diagnosis. In our study, suicide cases with cancer were common in elderly patients, those with a low educational background and individuals with a low income level (5% in this study vs. 1% in the national record). Among suicide cases with cancer, the most likely observed types of cancer were colorectal (14.7%), lung (12.1%) and liver (11.9%) cancer. However, the percentages of suicide in all mortality in cancers were the most noticeable in lip, oral cavity and pharynx cancer, particularly pharynx cancer. Several previous studies have confirmed that suicide is a competing cause of death among cancer patients, particularly for head and neck cancer survivors. 8, 11, 29, 30 Quality-of-life issues associated with head and neck cancer (e.g., pain, esthetic compromise and impaired body image) are associated with suicide. 31 Therefore, suicide in patients with cancer in general and head and neck cancers in particular should be addressed as a major threat to cancer survivorship.
11,29
Among all suicide cases with cancer, 1,185 (41%) suicide cases occurred within 1 year of cancer diagnosis. Miccinesi et al. 15 and Ahn et al. 18 similarly reported suicide rates of 40% within 1 year of cancer diagnosis. Our finding is higher than the suicide rate of 28-33% in Austria (33%). 32, 33 A Swedish study found young patients receiving a cancer diagnosis are at substantially increased risk of suicidal behavior (n 5 22 completed suicides), particularly during the 1st year after diagnosis. 34 Another study in Sweden reported that the relative risk of suicide during the first 3 month after cancer diagnosis was 4.8 and declined over the 3-12 month (RR 5 2.5) period compared with a cancer-free group. 1 This study was able to include a much larger number of completed suicides (n 5 2,907) to further illustrate the timing of the period of elevated suicide risk in the 1st year after cancer diagnosis.
Several studies have provided evidence supporting the elevated risk of suicide within 1 year after cancer diagnosis. 1, 16, 34, 35 However, the risk of suicide within the hazard period is unclear and few studies have involved unbiased comparison groups. Much attention has been paid to crossover design, which compares patients own data at different time points, because it overcomes complexities between cases and controls. Fang et al. in the United States 1 and Yamauchi et al. in Japan 36 have both used case-crossover analysis to depict the risk of suicide and found that the risk of suicide increased 2.6 and 13.0 times within 1 year after cancer diagnosis in comparison with that within 3 years before suicide. In our study, we used a case-crossover design to depict the monthly risk profile 1 year immediately after cancer diagnosis and found that cancer patients had the highest risk of suicide in the first month after cancer diagnosis. Such an elevated risk lasted for approximately half a year and remained stable for another 6 months relative to the 13th month. These findings indicate that clinicians specializing in cancer care should provide special attention to patients with newly diagnosed cancer to reduce their risk of suicide. In addition, although this study identified the 13th month before suicide as the control period, this does not imply that the suicide risk after 1 year of cancer diagnosis can be ignored. The side effects of primary treatment and relapse may cause emotional turmoil for patients 1 year after cancer diagnosis. In fact, cancer patients continue to exhibit high suicide risk after cancer diagnosis. Lu et al. (2013) found that suicide occurred on average 5.6 years after cancer diagnosis. 34 Notably, even 10 years after cancer diagnosis the patients still have elevated relative rates of mental disorder and suicide mortality. 37 The increased OR of suicide at the early phase of cancer diagnosis can be attributed to physical distress, functional limitation and the devastating effects of cancer treatment. 38 Korfage et al. found that the mental health of patients with prostate cancer was most intensely affected within the first 6 months. 39 The first half-year of a new cancer diagnosis can be considered a critical period for proactive suicide prevention efforts because the proximity of the time of cancer diagnosis is a necessary condition for cancer patients to commit suicide. Furthermore, among 208 suicide cases that occurred in the first month of cancer diagnosis, 82 (39.4%) patients had received only one time cancer diagnosis before committing suicide, implying that they did not obtain any further cancer treatment or follow-up. This finding also indicates that a patient-oriented diagnostic process and adjunct supportive psychoeducation regarding prognosis and treatment are needed to eliminate the emotional effect of cancer diagnosis. Further investigation of the period prior and close to cancer diagnosis should be conducted to identify whether patients exhibit signs, symptoms or comorbid mental disorders before diagnosis. This can enable suicide prevention strategies to be planned and implemented immediately upon cancer confirmation. The strengths of this study include the use of a population-based nationwide data set to derive longitudinal information on suicide, cancer and other associated factors. Another strength is the use of a case-crossover design to eliminate confounding factors embedded in different cases. This is the first study to examine the likelihood of monthly suicide risk during the 1-year period after cancer diagnosis by using longitudinal population-based data. This study provides evidence that the first 6 months is a critical time window for suicide prevention in patients with newly diagnosed cancer.
This study has several limitations. First, its main purpose was to reveal the odds of suicide after cancer diagnosis; other possible outcomes related to cancer diagnosis and suicide, such as the psychological impact, quality of life, possible post-traumatic stress disorder and cardiovascular mortality, were not investigated. 1 Second, premorbid mental status and pre-existing psychiatric conditions were not included in this study, which may have caused biases in the estimation of the effect of the timing of cancer diagnosis on the risk of suicide. However, we used a case-crossover design to reduce the possible interpersonal variations of mental health. Moreover, residual confounding that varies between hazard and control periods such as age (even within a year) may have affected our results.
Due to recent advances in medical technology, cancer is no longer incurable and many cancers can be detected at early stages and treated with aggressive and promising therapeutic modalities. The 5-year survival rates of many cancers have been improved considerably. A recent study has highlighted that the risk of non-cancer deaths have surpassed that of cancer deaths. 16 In this study, the 6-month period after the first cancer diagnosis of cancer was found to be the most risky period with respect to committing suicide. Therefore, this period is critical for suicide prevention. The 1-month period immediately after cancer diagnosis is the most critical phase because of the increased odds of committing suicide. Healthcare professionals who are in close contact with newly diagnosed cancer patients should enhance their sensitivity to possible mental distress and provide the necessary referrals to mental health specialists. These novel findings have important implications for establishing adequate follow-up involving suicide prevention strategies for cancer survivors.
